Evidence map›Paper›PMID 39456531›Full record

ArticleCancers2024

Radiotherapy with 15 × 2.633 Gy vs. 20 × 2.0 Gy in Patients with Malignant Spinal Cord Compression and Favorable Survival Prognoses: A Secondary Analysis of the RAMSES-01 Trial.

Dirk Rades, Darejan Lomidze, Natalia Jankarashvili, Fernando Lopez Campos, Arturo Navarro-Martin, Barbara Segedin, Blaz Groselj, Christian Staackmann, Nathan Y Yu, Jon Cacicedo

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Dirk RadesDepartment of Radiation Oncology, University of Lubeck, 23562 Lubeck, Germany.
Darejan LomidzeRadiation Oncology Department, Tbilisi State Medical University, Tbilisi 0177, Georgia.
Natalia JankarashviliDepartment of Radiation Oncology, Acad. F. Todua Medical Center-Research Institute of Clinical Medicine, Tbilisi 0112, Georgia.
Fernando Lopez CamposDepartment of Radiation Oncology, University Hospital Ramón y Cajal, 28034 Madrid, Spain.ORCID 0000-0002-4077-0507
Arturo Navarro-MartinDepartment of Radiation Oncology, Instituto Catalán de Oncología, 08908 l'Hospitalet de Llobregat, Barcelona, Spain.
Barbara SegedinDepartment of Radiotherapy, Institute of Oncology Ljubljana, 1000 Ljubljana, Slovenia.ORCID 0000-0003-0309-6282
Blaz GroseljDepartment of Radiotherapy, Institute of Oncology Ljubljana, 1000 Ljubljana, Slovenia.ORCID 0000-0003-4799-2978
Christian StaackmannDepartment of Radiation Oncology, University of Lubeck, 23562 Lubeck, Germany.
Nathan Y YuDepartment of Radiation Oncology, Mayo Clinic, Phoenix, AZ 85054, USA.
Jon CacicedoDepartment of Radiation Oncology, Cruces University Hospital, 48903 Barakaldo, Bizkaia, Spain.

Funding

European Regional Development Fund 094 -1.1-18
6 · The paper itself

Abstract

Many patients with malignant spinal cord compression (MSCC) who are not candidates for neurosurgery receive radiotherapy alone. This study compared 15 × 2.633 Gy over three weeks to 20 × 2.0 Gy over four weeks in patients with favorable survival prognoses. The outcomes of 34 patients treated with 15 × 2.633 Gy (equivalent dose 41.6 Gy

Indexed as

favorable survival prognosishigher dosesmalignant spinal cord compressionoverall treatment timeradiotherapy alonesecondary analysis

Identifiers

PMID39456531
PMCPMC11506761

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.